文献速递癫痫

癫痫母亲孕期使用高剂量叶酸与子代癌症风险

Cancer Risk in Children of Mothers With Epilepsy and High-Dose Folic Acid Use During Pregnancy.
PubMed 文献 · JAMA Neurol · 2022-01-01

该观察性队列研究利用丹麦、挪威和瑞典1997至2017年全国登记数据,纳入3 379 171名儿童,评估癫痫母亲孕期使用高剂量叶酸(≥1 mg/日)与子代20岁前癌症风险的关系。结果显示,癫痫母亲高剂量叶酸暴露子代的调整风险比(HR)为2.7(95% CI 1.2-6.3),而无癫痫母亲中该关联无统计学意义(HR 1.1,95% CI 0.9-1.4)。

要点

  • 癫痫母亲孕期使用高剂量叶酸(≥1 mg/日)与子代儿童期癌症风险升高相关(调整HR 2.7)。
  • 无癫痫母亲使用高剂量叶酸与子代癌症风险无显著关联(调整HR 1.1)。
  • 癫痫母亲未暴露高剂量叶酸时,子代癌症绝对风险为0.6%。

核心结论

  • 癫痫母亲孕期暴露于高剂量叶酸与子代癌症风险升高相关。

研究设计与样本

  • 观察性队列研究,使用丹麦、挪威和瑞典1997至2017年全国登记数据,纳入3 379 171名儿童。
  • 暴露为母亲从妊娠开始前90天至出生期间处方配取高剂量叶酸片(≥1 mg/日)。
  • 主要结局为20岁前儿童癌症首次发病,采用Cox比例风险模型计算调整风险比。

主要发现

  • 中位随访结束时年龄为7.3岁(IQR 3.5-10.9岁)。
  • 癫痫母亲子代中,5 934名(21.4%)暴露于高剂量叶酸(平均剂量4.3 mg),暴露组癌症18例 vs 未暴露组29例,调整HR 2.7(95% CI 1.2-6.3)。
  • 癫痫母亲子代中,暴露组20岁时绝对风险1.4%(95% CI 0.5%-3.6%) vs 未暴露组0.6%(95% CI 0.3%-1.1%)。
  • 无癫痫母亲子代中,46 646名(1.4%)暴露于高剂量叶酸(平均剂量2.9 mg),暴露组癌症69例 vs 未暴露组4 927例,调整HR 1.1(95% CI 0.9-1.4),绝对风险0.4%(95% CI 0.3%-0.5%)。
  • 癫痫母亲子代中,产前暴露于抗癫痫发作药物但未暴露高剂量叶酸者,癌症绝对风险0.6%(95% CI 0.2%-1.3%),与癌症风险增加无关联。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Women with epilepsy are recommended high doses of folic acid before and during pregnancy owing to risk of congenital anomalies associated with antiseizure medications. Whether prenatal exposure to high-dose folic acid is associated with increases in the risk of childhood cancer is unknown. OBJECTIVE: To assess whether high-dose folic acid supplementation in mothers with epilepsy is associated with childhood cancer. DESIGN, SETTING, AND PARTICIPANTS: Observational cohort study conducted with nationwide registers in Denmark, Norway, and Sweden from 1997 to 2017. Analyses were performed during January 10, 2022, to January 31, 2022. Mother-child pairs were identified in medical birth registers and linked with information from patient, prescription, and cancer registers, as well as with sociodemographic information from statistical agencies, and were categorized by maternal diagnosis of epilepsy. The study population consisted of 3 379 171 children after exclusion of 126 711 children because of stillbirth or missing or erroneous values on important covariates. EXPOSURES: Maternal prescription fills for high-dose folic acid tablets (≥1 mg daily) between 90 days before pregnancy start and birth. MAIN OUTCOMES AND MEASURES: First onset of childhood cancer at younger than 20 years. Cox proportional hazards models were used to calculate adjusted hazard ratios with corresponding 95% CIs, adjusted for potential confounders. Cumulative incidence at aged 20 years was used as a measure of absolute risk. RESULTS: The median age at the end of follow-up in the study population of 3 379 171 children was 7.3 years (IQR, 3.5-10.9 years). Among the 27 784 children (51.4% male) born to mothers with epilepsy, 5934 (21.4%) were exposed to high-dose folic acid (mean dose, 4.3 mg), with 18 exposed cancer cases compared with 29 unexposed, producing an adjusted hazard ratio of 2.7 (95% CI, 1.2-6.3), absolute risk if exposed of 1.4% (95% CI, 0.5%-3.6%), and absolute risk if unexposed of 0.6% (95% CI, 0.3%-1.1%). In children of mothers without epilepsy, 46 646 (1.4%) were exposed to high-dose folic acid (mean dose, 2.9 mg), with 69 exposed and 4927 unexposed cancer cases and an adjusted hazard ratio of 1.1 (95% CI, 0.9-1.4; absolute risk, 0.4% [95% CI, 0.3%-0.5%]). There was no association between children born to mothers with epilepsy who were prenatally exposed to antiseizure medications, but not high-dose folic acid, and an increased risk of cancer (absolute risk, 0.6%; 95% CI, 0.2%-1.3%). CONCLUSIONS AND RELEVANCE: Prenatal exposure to high-dose folic acid was associated with increased risk of cancer in children of mothers with epilepsy.

来源:JAMA Neurol,查看原文。版权归原作者所有。

引用

  1. Vegrim HM, Dreier JW, Alvestad S, et al. Cancer Risk in Children of Mothers With Epilepsy and High-Dose Folic Acid Use During Pregnancy. JAMA Neurol. 2022. PMID: 36156660. doi:10.1001/jamaneurol.2022.2977

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。